In Section C, members will acquire ABBV-744 and oral navitoclax. In Phase D, members will get ABBV-744 and ruxolitinib. Members will get treatment till condition progression or perhaps the individuals are not able to tolerate the study drugs. Achievable new strategies for your prognosis and treatment of AML. (A) The https://emperork555vfq7.bloggip.com/profile